Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Milagros Sancho-Gonzalez"'
Autor:
FJ García-Moreno, Roberto Collado-Borrell, María Olmedo, Maricela Valerio, Elena Lobato-Matilla, Beatriz Somoza-Fernandez, Ana Herranz, Juan Carlos Lopez-Bernaldo-de-Quirós, Teresa Aldámiz-Echevarría, Silvia Manrique-Rodríguez, Emilio Bouza, Sebastian Garcia-Sanchez, Irene Taladriz-Sender, RM Romero-Jiménez, Marina Machado, Paula Ruiz-Briones, Patricia Muñoz, Cecilia M. Fernández-Llamazares, Rafael Correa-Rocha, Milagros Sancho-Gonzalez, José Luis Revuelta-Herrero, Camino Sarobe-González, Alvaro Gimenez-Manzorro, CG Rodriguez-Gonzalez, Esther Chamorro-de-Vega, María Sanjurjo
Publikováno v:
Expert Review of Clinical Pharmacology
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Background: We report the long-term outcomes, changes in laboratory parameters, the incidence of secondary nosocomial infections and treatment cost of a Spanish cohort of patients with severe COVID-19 that received tocilizumab (TCZ). Methods: Retrosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c533ed6110c4c54469cd542550b561ee
Autor:
Francisco Tejerina, Cristina Villanueva-Bueno, Alvaro Gimenez-Manzorro, Alejandra Melgarejo-Ortuño, Juan Vicente-Valor, Alvaro Narrillos-Moraza, Ana Herranz, María Olmedo, Beatriz Torroba-Sanz, Silvia Manrique-Rodríguez, Miguel Ángel Amor-García, Esther Chamorro-de-Vega, Emilio Bouza, María Sanjurjo, Maricela Valerio, Vicente Escudero-Vilaplana, Marina Machado, Carmen Guadalupe Rodríguez-González, Patricia Muñoz, Milagros Sancho-Gonzalez
Publikováno v:
International Journal of Antimicrobial Agents
Highlights • Few large series have described the clinical characteristics, treatments, costs and outcomes of COVID-19 patients in western countries. • We report our experience with the first 1,255 cases who received anti-COVID-19 treatment at a S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b63e690ff6d4d00dfe57545d208893e
https://pubmed.ncbi.nlm.nih.gov/33259918
https://pubmed.ncbi.nlm.nih.gov/33259918
Autor:
Bárbara Balandin, Marta Chicot, Vicente Pintado, Cruz Soriano-Cuesta, Loreto López-Vergara, Daniel Ballesteros, Reyes Iranzo, Milagros Sancho-Gonzalez, Inamculada Fernández-Simón, Ana Royuela, Rafael Ruiz de Luna, Maria José Asensio-Martín, Alberto Silva, Fernando Martínez-Sagasti, Maria José Pérez-Pedrero, Diego Rodriguez-Serrano
Publikováno v:
International Journal of Antimicrobial Agents. 57:106270
This study aimed to assess the efficacy of ceftolozane-tazobactam (C/T) for treating infections due to Pseudomonas aeruginosa (P. aeruginosa) in critically ill patients.A multicenter, retrospective and observational study was conducted in critically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a1229e15ef678d3f551c6ec63aad5e
https://doi.org/10.1016/j.ijantimicag.2020.106270
https://doi.org/10.1016/j.ijantimicag.2020.106270
Autor:
Chamorro-de-Vega, Esther, Rodriguez-Gonzalez, Carmen-Guadalupe, Manrique-Rodríguez, Silvia, Lobato-Matilla, Elena, García-Moreno, Felix, Olmedo, Maria, Correa-Rocha, Rafael, Valerio, Maricela, Aldámiz-Echevarria, Teresa, Machado, Marina, Sancho-Gonzalez, Milagros, Lopez-Bernaldo-de-Quirós, Juan Carlos, Ruiz-Briones, Paula, Romero-Jiménez, Rosa, Sarobe-González, Camino, Gimenez-Manzorro, Alvaro, Collado-Borrell, Roberto, Fernandez-Llamazares, Cecilia M, Revuelta-Herrero, Jose Luis, Somoza-Fernandez, Beatriz
Publikováno v:
Expert Review of Clinical Pharmacology; Feb2021, Vol. 14 Issue 2, p249-260, 12p